To reflect at least in part the diversity of immune mediators found in cHL, moDC were treated with a cytokine cocktail (TNFα/IL10/TGFβ) or with SN of cHL cell lines L1236 and HDLM2. The gene discussed is TNF; the disease is classic Hodgkin lymphoma.